BCT, breast-conserving therapy; IBC, inflammatory breast cancer; NAC, neoadjuvant chemotherapy; LABC, locally advanced breast cancer; HER2, human epidermal growth factor receptor-2; RCT, randomized controlled trial; SEER, Surveillance, Epidemiology, and End Results. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.